Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares to cover tax obligations related to vested RSUs.
Summary
- On July 20, 2024, Matthew Gline, CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to cover tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $11 per share.
- Following the transaction, Gline directly owns 1,120,871 common shares.
Sentiment
Score: 5
Explanation: This is a neutral event. It reflects a standard procedure for covering tax obligations related to executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard practice of covering tax obligations related to RSU vesting.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 07/20/2024 | Date of transaction: Matthew Gline disposed of 10,945 common shares. |
| 07/25/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.